UK’s GSK announces  billion U.S. pharma investment amid Trump state visit

UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit

Rafael Henrique | Lightrocket | Getty Images British pharmaceutical giant GSK on Wednesday committed to investing at least $30 billion in U.S. research and developing (R&D) and manufacturing over the coming five years. The investment includes $1.2 billion toward advanced manufacturing, AI and advanced digital technologies to deliver “next-generation biopharma factories and laboratories in the…

Read More